This study was designed to evaluate the effect of sufentanil, tramadol or clonidine added to lignocaine for intravenous regional anaesthesia. We investigated the onset and duration of sensory and motor block, the quality of the anaesthesia, intraoperative and postoperative haemodynamics, intraoperative and postoperative pain and sedation.
Intravenous regional anaesthesia (IVRA) is a technically simple and reliable technique, with success rates between 94% and 98% 1 . IVRA is a form of regional anaesthesia in which tourniquet pressure is exerted on the limb proximally, isolating it from the systemic circulation while local anaesthetic is injected intravenously. The method was first used by August Bier. In 1963, Holmes successfully used lignocaine as the local anaesthetic and the technique achieved popularity 2 .
The application of IVRA is limited by tourniquet pain, and the inability to provide postoperative analgesia 3 . One of the problems compared to peripheral nerve block is that there is no prolonged analgesic effect after tournique release. The addition of adjuvants improves tolerance of tourniquet pain but has little effect on postoperative pain. To improve the quality of IVRA block, various opioids added to local anesthetic have been investigated with conflicting results. Recent meta-analyses concluded that opioids lack significant effect in this setting 4, 5 .
Sufentanil is a synthetic opioid analgesic 6 and clonidine induces analgesia mainly through stimulation of α 2 -adrenergic receptors in the dorsal horn of the spinal cord 7, 8 . Tramadol is a synthetic analgesic which structurally resembles codeine. The central effect of tramadol is mainly due to its effect on neurons contributing to the monoaminergic modulation of pain rather than opioid receptor activity 9, 10 . Our aim was to compare sufentanil, tramadol and clonidine when added to local anaesthetic, in order to determine which was most effective.
MATERIAL AND METHODS
Sixty ASA physical status I patients scheduled for surgery of the hand or the forearm (for example carpal tunnel release and tendon release) were included in this study after giving informed consent and following ethical committee approval. Patients with Raynaud's disease, sickle cell anaemia or a history of allergy to any drug used were excluded. The study was of randomized, double-blind design, with the computer-generated randomization list used by personel blinded to the study to prepare identical syringes containing the allocated drug. As premedication, midazolam 0.15 mg.kg -1 and atropine 0.01 mg.kg -1 were administered intramuscularly (IM) 45 minutes before the surgical procedure. In the surgical room mean arterial pressure (MAP), peripheral oxygen saturation (SpO 2 ), and heart rate (HR) were monitored (Dräger Cato PM 8040, Lübeck, Germany).
Before establishing the anaesthetic block, two cannulae were placed; one in a vein on the dorsum of the operative hand and the other in the opposite hand for crystalloid infusion. The operative arm was elevated for three minutes for exsanguination before application of an Esmarch bandage. A double-cuff pneumatic tourniquet (Tourniquet 2800 ELC, UMB, Medizintecknik, GmbH, Germany) was placed around the upper arm and the proximal cuff inflated to 250 mmHg. Circulatory isolation of the arm was verified by inspection, absence of the radial pulse and loss of the pulse oximetry tracing from the ipsilateral index finger. IVRA was achieved using lignocaine 0.5% 35 ml, (Aritmal, TEMS, Turkey) diluted with saline 5 ml to a total volume of 40 ml in the control group (Group L, n=15) or a similar final volume including 0.5% lignocaine 35 ml and sufentanil (Janssen Pharmaceutica, Beerse, Belgium) 25 µg (Group LS, n=15); tramadol (Contramal, Abdi Ibrahim, Turkey) 100 mg (Group LT, n=15) or clonidine (Catapresan, Bochinger Ingelheim, Germany) 1 µg.kg -1 (Group LC, n=15).
The sensory block was assessed using pinprick performed with a 22-gauge short-bevelled needle every 30 seconds. Patient response was evaluated in the dermatomal sensory distribution of the medial and lateral antebrachial cutaneous, ulnar, median and radial nerves. Motor function was assessed by asking the subject to flex and extend his wrist and fingers and complete motor block was noted when no voluntary movement was possible. Sensory block onset time was considered the time elapsed from injection of study drug until sensory block was achieved in all dermatomes and motor block onset the time elapsed from injection of study drug to complete motor block.
After sensory and motor block was achieved, the distal cuff was inflated to 250 mmHg followed by release of the proximal tourniquet and the operation was started. MAP, HR, and SpO 2 were monitored before and after tourniquet application, and 5, 10, 15, 20, and 40 minutes after the injection of anaesthetic by an anaesthetic resident unaware of group allocation. Hypotension (defined as a 25% decrease from basealine) was treated with intravenous (IV) ephedrine (3 to 9 mg bolus); bradycardia (25% decrease from baseline) with IV atropine 0.5 mg and SaO 2 <91% was treated with oxygen (O 2 ) supplementation via a facemask.
Assessment of tourniquet pain was made on the basis of the visual analogue scale (VAS) where 0="no pain" and 10="worst pain imaginable" and degree of sedation (scale 1-5, 1=completely awake, 2=awake but drowsy, 3=asleep but responsive to verbal commands, 4=asleep but responsive to tactile stimulus, 5=asleep and not responsive to any stimulus) 11 was measured before and after tourniquet application and 5, 10, 15, 20, and 40 min after the injection of anaesthetic. Intraoperatively, boluses of 1 µg.kg -1 fentanyl (Fentanil Citrate, Abbott, North Chigaco, U.S.A.) were provided for tourniquet pain treatment when required (VAS >3) and total fentanyl consumption was recorded.
At the end of the operation, the surgeon, who was also unaware of group allocation, was asked to quantify the operative conditions and dryness of the operative field according to the numeric scale: 0=unsuccessful, 1=poor, 2=acceptable and 3=perfect. All operations were performed by the same surgeon. The resident was also asked to quantify the operative conditions according to a numeric scale: 4=excellent, no complaint from patient, 3=good, minor complaint with no need for supplemental analgesics, 2=moderate, complaint which required supplemental analgesics, and 1=unsuccessful, patient given general anesthesia.
The tourniquet was not deflated before 30 minutes and was not inflated for more than 1.5 hours. At the end of surgery, the tourniquet deflation was performed using a cyclic deflation technique. The sensory recovery time (defined as the time elapsed from tourniquet deflation until recovery of pain in all dermatomes, as determined by pinprick testing) was noted. Motor block recovery time was defined as the time elapsed after tourniquet release until the first patient request for analgesic.
The MAP, HR, pain and sedation levels were recorded 30 minutes after tourniquet application and at 2, 4, 6, 12, and 24 hours. Patients were prescribed 75 mg IM diclofenac (Voltaren, Ciba-Geigy, Turkey) when the VAS was >3 and the total amount of diclofenac administered to each group was recorded. The duration of analgesia was defined as the time elapsed from tourniquet release to the first oral intake of diclofenac. If no diclofenac was necessary within 24 hours, the duration of analgesia was counted as 24 hours.
During the study period, any local or systemic complications were recorded and measurements in all patients were performed by the same person.
The statistical evaluation was perfomed using the MINITAB INC. (no: WCP1331.00197) program. We considered that a clinically significant benefit of using sufentanil, tramadol, clonidine would be a reduction in the tourniquet pain score (VAS) of 15% compared to the control group. Fifteen patients in each group was required based on a type I error of α=0.05 and power of 80%. Student's t-test and analysis of variance (ANOVA) were used for evaluation of the demographic data, preoperative, postoperative, intraoperative haemodynamic data, the time of onset and recovery of the sensory and motor block, duration of the operation and tourniquet, onset time of the tourniquet pain, duration of analgesia time, the quality of anaesthesia and dryness of the operative field. As the onset time of the tourniquet pain showed significant differences on ANOVA, the Mann Whitney-U test was used for the significance of results. Because the data of intraoperative, postoperative VAS and sedation, intraoperative consumption of opioids and postoperative analgesic use were not normally distributed, the Kruskall Wallis test was applied and Mann Whitney-U test used for significance testing. General log linear analysis was applied to investigate the overall relationship and to cross compare the categorical scores. P<0.05 was considered statistically significant.
RESULTS
Sixty patients (n=15 in each group) were enrolled. There were no exclusions because of technical failure. No patient needed treatment for hypotension or bradycardia. The SpO 2 (96% mean value through study) was always within the clinically acceptable range. The mean patient age and weight, the duration of surgery and tourniquet inflation did not differ between groups ( Table 1 ). The sensory block onset time was longer in group L (P<0.001). Sensory recovery times and motor block onset and recovery times were not different between groups (Table 2) .
There was no difference between groups for MAP, HR, and SpO 2 at any preoperative and intraoperative time. There was no difference between groups in scores for tourniquet pain before and after tourniquet inflation, and at 5 min, 10 min, 15 min, but at 20 and 40 min, there was a statistically significant increase in group L when compared with the other groups (P<0.05) ( Table 3) . Compared with other groups the initial time to tourniquet pain was significantly shorter in Group L and the total dose of fentanyl administered was significant higher (P<0.05) ( Table 4 ). The sedation scores did not differ between groups (Table 3 ).
The quality of anaesthesia rating determined by the anaesthetic resident was 4 (3-4), 4 (3-4), 4 (3-4) for Groups LS, LT and LC respectively and this was significantly better than group L (3 (1-4), (P<0.05). There was no difference between groups for rating of anaesthetic quality or dryness of the operative field as assessed by the surgeon. Postoperatively, groups were comparable MAP, HR, and for VAS scores, sedation level, analgesic consumption and duration of analgesia (Table 4 ).
There were no exclusions because of insufficient anaesthesia and the side-effects did not differ significantly between groups (Table 5) .
DISCUSSION
Tramadol has a dual mechanism of action, blocking the reuptake of noradrenaline and 5-hydroxytryptamine at the level of α 2 -adrenergic receptors 12, 13 . Pretreatment with α-adrenoreceptor antagonists yohimbine and idazoxan results in a significant reduction of its antinociceptive effect 14, 15 . Acalovschi et al 13 found that addition of tramadol 100 mg resulted in a shorter onset time of sensory block in IVRA. They suggested that tramadol might modify the action of a local anaesthetic and we also found a reduction in the sensory block onset in Group LT compared with Group L. Tourniquet pain and total fentanyl consumption were also reduced by a tramadol-containing lignocaine solution in our study. Tan et al 16 assessed whether the addition of tramadol 50 mg to 30 ml 0.5% lignocaine improved the efficacy of IVRA. They found significantly lower pain scores 30 min after tourniquet inflation and after changeover to the distal tourniquet. In contrast, Langlois et al 17 found no difference in tourniquet tolerance or pain. In the latter study, the tourniquet inflation time was shorter (proximal tourniquet 21±4 min, distal tourniquet 27±4 min) than in our study (tourniquet time 52±15) and that of Tan et al 16 . Because the incidence and intensity of tourniquet pain increases with time, a longer duration of tourniquet inflation might have revealed the analgesic effect of tramadol. The only side-effect reported after tramadol has been combined with lignocaine was a skin rash below the tourniquet that disappeared within one hour of deflation 12 .
In a study of the addition of sufentanil to local anaesthetic, Hoffmann et al 18 found that development of a complete sensory block was significantly faster in patients receiving additional sufentanil 25 µg compared with plain prilocaine alone for IVRA. Sufentanil has some local anaesthetic activity with depression of A and C fibre action potentials 19 . In our TABLE 3 Changes in pain and sedation during the intraoperative period
Groups
Before tourniquet After tourniquet AT 5 min AT 10 min AT 15 min AT 20 min AT 40 min
N=15 per group. Values are median (range). AT=after tourniquet. *P<0.05 Group L versus Groups LS, LT, and LC. Group L  ---2  2  -2  -6  Group LS  ---1  --2  2  5  Group LT  -1  1  -2  1  1  -6  Group LC  2  --3  ----5 study we also found sensory block onset time was more rapid with the addition of the same dose of sufentanil to plain lignociane, but sensory recovery times and motor block onset and recovery times were not different. Hoffman et al 18 reported lightheadedness after tourniquet deflation in 8 of 15 patients while we observed light-headedness in two subjects.
Reuben et al 20 evaluated the safety and efficacy of administering IVRA with 1 µg.kg -1 clonidine in the management of complex regional pain syndrome of the knee and found it useful and without significant side-effects. Gorgias et al 21 evaluated the safety and efficacy of IVRA including 1 µg.kg -1 clonidine and also found this to be well tolerated. In our study, we found that sensory block onset time was reduced in Group LC compared with Group L, although sensory recovery times and motor block onset and recovery times were not different from other groups. Kleinschmidt et al 22 combined prilocaine 0.5% with clonidine (2 µg.kg -1 ) and found no significant differences in sensory and motor block characteristics. In our opinion, these conflicting results could be related to their use of a healthy volunteer group and a different anaesthetic agent. Gorgias et al 21 and Lurie et al 23 compared the efficacy of a 1 µg.kg -1 clonidine added to lignocaine for IVRA and found it delayed the onset of unbearable tourniquet pain and decreased analgesic consumption. Tourniquet pain and total fentanyl consumption were also reduced by a similar clonidine-containing lignocaine solution in our study. Kleinschmidt et al 22 and Gentili et al 11 reported that a larger dose of clonidine (2 µg.kg -1 or 150 µg) resulted in sedation or hypotension upon tourniquet deflation. The smaller dose of clonidine (1 µg.kg -1 ) used by Reuben et al 24 and Lurie et al 23 appears to be well tolerated and we also found no haemodynamic changes or sedation postoperatively in the group receiving clonidine.
Pain is a common problem complicating the use of a pneumatic tourniquet during surgical procedures involving the upper or lower limb and one of the main problems associated with IVRA. The mechanism of tourniquet pain remains unclear despite the involvement of A fibres and unmyelinated C fibres 25 . Our study shows that sulfentanil, tramadol and clonidine delay the onset of the tourniquet pain and reduce its severity. This may be because of local anaesthetic activity.
Like Hoffmann et al 18 and Langlois et al 17 , we found no postoperative benefit from the addition of sufentanil or tramadol, respectively, in IVRA. Results of studies reporting on the postoperative analgesic effects of clonidine have conflicted. Gentili et al 11 found no difference in pain scores, although these were only followed for 60 min and were low in both treatment and control groups. Reuben et al 24 studied the effect of clonidine 1 µg.kg -1 on postoperative analgesia and reported a number of significant effects. Cultural differences in the expression of pain may account for conflicting outcomes and one of the limitations of our study is the small number of patients. Further investigatons are needed to determine the efficacy and safety of clonidine in IVRA.
In conclusion, we observed that the addition to lignocaine of sulfentanil, tramadol or clonidine for IVRA shortened the onset time of the sensory block, delayed the onset of tourniquet pain and reduced the intraoperative consumption of opioids without altering postoperative pain.
